Hirano Patricia C 的 Form 4 申報
Soleno Therapeutics IncSLNO，2024/8/7 申報
- 申報編號
- 0001415889-24-020944
- 申報時間
- 2024/8/7
- 交易日
- 2024/8/5-8/6
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $50.2 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Hirano Patricia CCIK 0001766042 | 高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/8/5 | Common Stock | S賣出處分 | −2,834 | $45.48F2 | −$128,890.32 | 130,920 | 直接 | |
| 2024/8/5 | Common Stock | S賣出處分 | −2,198 | $46.14F4 | −$101,415.72 | 128,722 | 直接 | |
| 2024/8/6 | Common Stock | S賣出處分 | −587 | $43.64F5 | −$25,616.68 | 128,135 | 直接 | |
| 2024/8/6 | Common Stock | S賣出處分 | −1,983 | $45.25F6 | −$89,730.75 | 126,152 | 直接 | |
| 2024/8/6 | Common Stock | S賣出處分 | −3,407 | $45.89F7 | −$156,347.23 | 122,745 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $44.87 to $45.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $45.87 to $46.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $43.245 to $44.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $44.66 to $45.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $45.66 to $46.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
備註
Officer title: Senior Vice President, Regulatory Affairs